Growth Metrics

Dr Reddys Laboratories (RDY) Consolidated Net Income (2016 - 2025)

Historic Consolidated Net Income for Dr Reddys Laboratories (RDY) over the last 17 years, with Q4 2025 value amounting to $133.6 million.

  • Dr Reddys Laboratories' Consolidated Net Income fell 1965.63% to $133.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $316.9 million, marking a year-over-year decrease of 3647.85%. This contributed to the annual value of $671.0 million for FY2025, which is 44.91% up from last year.
  • Dr Reddys Laboratories' Consolidated Net Income amounted to $133.6 million in Q4 2025, which was down 1965.63% from $183.3 million recorded in Q1 2025.
  • Over the past 5 years, Dr Reddys Laboratories' Consolidated Net Income peaked at $183.3 million during Q1 2025, and registered a low of $152.0 during Q3 2022.
  • For the 5-year period, Dr Reddys Laboratories' Consolidated Net Income averaged around $131.6 million, with its median value being $154.0 million (2022).
  • As far as peak fluctuations go, Dr Reddys Laboratories' Consolidated Net Income crashed by 9999.98% in 2022, and later skyrocketed by 11778634501.85% in 2023.
  • Quarter analysis of 5 years shows Dr Reddys Laboratories' Consolidated Net Income stood at $11.0 million in 2021, then soared by 962.09% to $116.8 million in 2022, then surged by 45.52% to $170.0 million in 2023, then fell by 2.21% to $166.3 million in 2024, then decreased by 19.66% to $133.6 million in 2025.
  • Its Consolidated Net Income stands at $133.6 million for Q4 2025, versus $183.3 million for Q1 2025 and $166.3 million for Q4 2024.